Categoría: Geovanny Vicente

BRONX, N.Y., Feb. 18, 2021 /PRNewswire-HISPANIC PR WIRE/ — Last December, 70-year-old Bronx resident Irma Vega got COVID-19. Like 52 percent of people living in the Bronx, Vega had multiple chronic conditions, meaning her case of COVID-19 could easily become life-threatening. After her positive test, she arrived at Montefiore Medical Center to begin monoclonal antibody treatment.

Monoclonal antibodies are created in a lab and function like naturally occurring antibodies, fighting infections before they spread. Studies show that when monoclonal antibodies are given intravenously to high-risk people diagnosed early with COVID-19, it can prevent them from experiencing severe symptoms that lead to hospitalizations.

«COVID-19 is a horrible illness, but I trusted the doctors and nurses,» said Vega. «I started monoclonal antibodies and my symptoms never got worse. I never needed to go to the hospital.»

Today more than 470 patients like Vega have benefited from Montefiore’s monoclonal antibody program, 93 percent of whom avoided worsening symptoms that would have required a visit to the hospital.

«Longstanding inequities and chronic disease have led to high COVID-19 infection rates and significant risk of death in our borough,» said Dr. Priya Nori, director of the Antibiotic Stewardship Program, an infectious disease specialist at Montefiore Health System, and associate professor of medicine at Albert Einstein College of Medicine. «Now Bronx residents have a safe, evidence-based treatment that stops COVID-19 in its tracks and is preventing severe illness.»

In December, Dr. Nori’s team began treating patients in Montefiore’s Bronx emergency departments with monoclonal antibodies, which are developed by pharmaceutical companies and authorized by the Food and Drug Administration. Since then, Montefiore opened an infusion clinic – now the main location for this therapy – and is partnering with local nursing homes to treat their residents.

People who qualify for monoclonal antibodies have a high-risk of severe COVID-19, including people aged 65 or older, and illnesses like chronic kidney disease, diabetes, hypertension, coronary artery disease, obesity and COPD. People who are immunocompromised due to diseases such as cancer, lupus or sickle cell anemia, or organ transplant recipients, are also candidates for treatment. Pregnant women and high-risk patients under age 21 may also qualify.

The monoclonal antibody treatment is given using IV therapy, administered through a vein in the arm, for about an hour. Patients are evaluated by a nurse practitioner and then monitored for any allergic reactions, which are extremely rare.  The appointment takes about three hours to complete; afterward patients receive a follow-up phone visit. Less than two weeks later, a telehealth appointment is completed with an infectious disease doctor who reviews recovery and symptoms.

«Patients come in with fear of COVID-19 and leave with hope because of this treatment,» said Susan Sakalian, Oncology Certified Nurse at Montefiore Medical Center. «It is a huge step forward from where we were in March 2020. The infusions keep people from needing emergency care, and that’s an invaluable resource for our patients and their families.»

For more information about the monoclonal antibodies treatment, please visit  covid19.montefiore.org/monoclonal-antibody-therapy-montefiore#main-content.

About Montefiore Health System
Montefiore Health System is one of New York’s premier academic health systems and is a recognized leader in providing exceptional quality and personalized, accountable care to approximately three million people in communities across the Bronx, Westchester and the Hudson Valley. It is comprised of 10 hospitals, including the Children’s Hospital at Montefiore, Burke Rehabilitation Hospital and more than 200 outpatient ambulatory care sites. The advanced clinical and translational research at its medical school, Albert Einstein College of Medicine, directly informs patient care and improves outcomes. From the Montefiore-Einstein Centers of Excellence in cancer, cardiology and vascular care, pediatrics, and transplantation, to its preeminent school-based health program, Montefiore is a fully integrated healthcare delivery system providing coordinated, comprehensive care to patients and their families. For more information please visit www.montefiore.org. Follow us on Twitter and view us on Facebook and YouTube.

About Albert Einstein College of Medicine
Albert Einstein College of Medicine is one of the nation’s premier centers for research, medical education and clinical investigation. During the 2020-21 academic year, Einstein is home to 721 M.D. students, 178 Ph.D. students, 109 students in the combined M.D./Ph.D. program, and 265 postdoctoral research fellows. The College of Medicine has more than 1,900 full-time faculty members located on the main campus and at its clinical affiliates. In 2020, Einstein received more than $197 million in awards from the National Institutes of Health (NIH). This includes the funding of major research centers at Einstein in aging, intellectual development disorders, diabetes, cancer, clinical and translational research, liver disease, and AIDS. Other areas where the College of Medicine is concentrating its efforts include developmental brain research, neuroscience, cardiac disease, and initiatives to reduce and eliminate ethnic and racial health disparities. Its partnership with Montefiore, the University Hospital and academic medical center for Einstein, advances clinical and translational research to accelerate the pace at which new discoveries become the treatments and therapies that benefit patients. Einstein runs one of the largest residency and fellowship training programs in the medical and dental professions in the United States through Montefiore and an affiliation network involving hospitals and medical centers in the Bronx, Brooklyn and on Long Island. For more information, please visit www.einstein.yu.edu, read our blog, follow us on Twitter, like us on Facebook, and view us on YouTube.

Photo – https://mma.prnewswire.com/media/1440703/Nori_Priya_2013_05_55.jpg
Logo – https://mma.prnewswire.com/media/675671/Montefiore_Logo.jpg

SOURCE Montefiore Health System

BRONX, N.Y., Feb. 18, 2021 /PRNewswire/ — Last December, 70-year-old Bronx resident Irma Vega got COVID-19. Like 52 percent of people living in the Bronx, Vega had multiple chronic conditions, meaning her case of COVID-19 could easily become life-threatening. After her positive test, she arrived at Montefiore Medical Center to begin monoclonal antibody treatment.

Monoclonal antibodies are created in a lab and function like naturally occurring antibodies, fighting infections before they spread. Studies show that when monoclonal antibodies are given intravenously to high-risk people diagnosed early with COVID-19, it can prevent them from experiencing severe symptoms that lead to hospitalizations.

«COVID-19 is a horrible illness, but I trusted the doctors and nurses,» said Vega. «I started monoclonal antibodies and my symptoms never got worse. I never needed to go to the hospital.»

Today more than 470 patients like Vega have benefited from Montefiore’s monoclonal antibody program, 93 percent of whom avoided worsening symptoms that would have required a visit to the hospital.

«Longstanding inequities and chronic disease have led to high COVID-19 infection rates and significant risk of death in our borough,» said Dr. Priya Nori, director of the Antibiotic Stewardship Program, an infectious disease specialist at Montefiore Health System, and associate professor of medicine at Albert Einstein College of Medicine. «Now Bronx residents have a safe, evidence-based treatment that stops COVID-19 in its tracks and is preventing severe illness.»

In December, Dr. Nori’s team began treating patients in Montefiore’s Bronx emergency departments with monoclonal antibodies, which are developed by pharmaceutical companies and authorized by the Food and Drug Administration. Since then, Montefiore opened an infusion clinic – now the main location for this therapy – and is partnering with local nursing homes to treat their residents.

People who qualify for monoclonal antibodies have a high-risk of severe COVID-19, including people aged 65 or older, and illnesses like chronic kidney disease, diabetes, hypertension, coronary artery disease, obesity and COPD. People who are immunocompromised due to diseases such as cancer, lupus or sickle cell anemia, or organ transplant recipients, are also candidates for treatment. Pregnant women and high-risk patients under age 21 may also qualify.

The monoclonal antibody treatment is given using IV therapy, administered through a vein in the arm, for about an hour. Patients are evaluated by a nurse practitioner and then monitored for any allergic reactions, which are extremely rare.  The appointment takes about three hours to complete; afterward patients receive a follow-up phone visit. Less than two weeks later, a telehealth appointment is completed with an infectious disease doctor who reviews recovery and symptoms.

«Patients come in with fear of COVID-19 and leave with hope because of this treatment,» said Susan Sakalian, Oncology Certified Nurse at Montefiore Medical Center. «It is a huge step forward from where we were in March 2020. The infusions keep people from needing emergency care, and that’s an invaluable resource for our patients and their families.»

For more information about the monoclonal antibodies treatment, please visit  covid19.montefiore.org/monoclonal-antibody-therapy-montefiore#main-content.

About Montefiore Health System
Montefiore Health System is one of New York’s premier academic health systems and is a recognized leader in providing exceptional quality and personalized, accountable care to approximately three million people in communities across the Bronx, Westchester and the Hudson Valley. It is comprised of 10 hospitals, including the Children’s Hospital at Montefiore, Burke Rehabilitation Hospital and more than 200 outpatient ambulatory care sites. The advanced clinical and translational research at its medical school, Albert Einstein College of Medicine, directly informs patient care and improves outcomes. From the Montefiore-Einstein Centers of Excellence in cancer, cardiology and vascular care, pediatrics, and transplantation, to its preeminent school-based health program, Montefiore is a fully integrated healthcare delivery system providing coordinated, comprehensive care to patients and their families. For more information please visit www.montefiore.org. Follow us on Twitter and view us on Facebook and YouTube.

About Albert Einstein College of Medicine
Albert Einstein College of Medicine is one of the nation’s premier centers for research, medical education and clinical investigation. During the 2020-21 academic year, Einstein is home to 721 M.D. students, 178 Ph.D. students, 109 students in the combined M.D./Ph.D. program, and 265 postdoctoral research fellows. The College of Medicine has more than 1,900 full-time faculty members located on the main campus and at its clinical affiliates. In 2020, Einstein received more than $197 million in awards from the National Institutes of Health (NIH). This includes the funding of major research centers at Einstein in aging, intellectual development disorders, diabetes, cancer, clinical and translational research, liver disease, and AIDS. Other areas where the College of Medicine is concentrating its efforts include developmental brain research, neuroscience, cardiac disease, and initiatives to reduce and eliminate ethnic and racial health disparities. Its partnership with Montefiore, the University Hospital and academic medical center for Einstein, advances clinical and translational research to accelerate the pace at which new discoveries become the treatments and therapies that benefit patients. Einstein runs one of the largest residency and fellowship training programs in the medical and dental professions in the United States through Montefiore and an affiliation network involving hospitals and medical centers in the Bronx, Brooklyn and on Long Island. For more information, please visit www.einstein.yu.edu, read our blog, follow us on Twitter, like us on Facebook, and view us on YouTube.

View original content to download multimedia:http://www.prnewswire.com/news-releases/hundreds-of-people-at-risk-for-severe-covid-19-avoid-hospitalization-with-new-treatment-301231079.html

SOURCE Montefiore Health System

ARLINGTON, Va., Feb. 18, 2021 /PRNewswire/ — Bloomberg Law today announced the availability of its 2021 Outlook on Bankruptcy, which incorporates news, analysis, and a subset of the most recent Practical Guidance available to subscribers on its platform. The Outlook report is accessible for complimentary download at http://onb-law.com/Yost50DDENB.

The 2021 Outlook on Bankruptcy features:

• News related to the uptick in bankruptcy filings and a closer look at trends across some of the industries that have been most impacted, including hospitality and retail, which saw its largest number of filings in more than a decade.
• Analysis by Bloomberg Law’s expert analyst team, which looks at the many lease- and rent-related bankruptcy amendments in the recently enacted Consolidated Appropriations Act, 2021 (CAA) and how the 2019 Small Business Reorganization Act has proven to be a useful tool for small businesses struggling due to the Covid-19 pandemic.
• Practical Guidance including a temporary pandemic-related Bankruptcy Code provisions table which provides an at-a-glance overview of amendments made by Congress in the past year to the Bankruptcy Code in the Coronavirus Aid, Relief, and Economic Security (CARES) Act and the CAA.

«The Covid-19 pandemic and accompanying downturn has led to many businesses declaring bankruptcy or having to contemplate it,» said Joe Breda, President, Bloomberg Law. «These businesses must now deal with a significant number of changes to the Bankruptcy Code – and with a new administration we anticipate additional changes. Bloomberg Law’s subscribers, however, can be confident that we will stay on top of developments from Congress, the administration, and the federal judiciary to help them understand the impacts on their bottom line.»

About Bloomberg Law

Bloomberg Law helps legal professionals provide world-class counsel with access to actionable legal intelligence in a business context. Bloomberg Law delivers a unique combination of comprehensive primary and secondary source material, real-time news, expert analysis, time-saving practice tools including Practical Guidance, market data, and business intelligence. For more information, visit pro.bloomberglaw.com.

View original content to download multimedia:http://www.prnewswire.com/news-releases/impact-of-covid-19-among-issues-at-forefront-of-bloomberg-law-bankruptcy-outlook-301231076.html

SOURCE Bloomberg Law

SEATTLE, Feb. 18, 2021 /PRNewswire/ — Milliman, Inc., one of the premier global consulting and actuarial firms, today announced a stellar line-up of over 50 influential leaders across business, government, academia, and not-for-profit sectors who will speak at the inaugural Milliman Climate Resilience Forum (MCRF), March 2 – 4, 2021. The Milliman Climate Resilience Forum will unite varying perspectives as experts from around the globe discuss how the cascading effects of climate change could impact industry and society, and the steps needed to improve our resilience.

 Register now for #MCRF2021, which is free to attend and open to all. Here are just some of the key voices who will be speaking during the three-day event, March 2 – 4:

• Alice Hill, Council on Foreign Relations
• Denis Duverne, AXA, Insurance Development Forum
• Spencer Glendon, Probable Futures
• Anna Sweeney, Bank of England
• Samantha Medlock, U.S. House Select Committee on the Climate Crisis
• Olivier Mahul, World Bank
• Ricardo Lara, California Department of Insurance
• Sarah Russell, X, the moonshot factory
• Michael Grimm, FEMA
• Don Kanak, Prudential Insurance Growth Markets

Each day will focus on a specific challenge central to climate resilience: How is climate risk anticipated, measured, and communicated?  What are legislators and regulators doing to protect society from climate risk? How is industry innovating and adapting for climate change?

Going beyond the traditional virtual event, the Milliman Climate Resilience Forum allows registrants the opportunity to network and chat with other attendees, with the goal of delivering insight, inspiration, and discussion. To see the full speaker list and agenda, and to register, go to https://mcrf.milliman.com/s/registration-page/home. 

About Milliman

Milliman is among the world’s largest providers of actuarial and related products and services. The firm has consulting practices in healthcare, property & casualty insurance, life insurance and financial services, and employee benefits. Founded in 1947, Milliman is an independent firm with offices in major cities around the globe.  For further information, visit milliman.com.

View original content to download multimedia:http://www.prnewswire.com/news-releases/50-global-leaders-to-address-the-cascading-effects-of-climate-change-at-inaugural-milliman-climate-resilience-forum-301230914.html

SOURCE Milliman, Inc.

NEW YORK, Feb. 18, 2021 /PRNewswire/ — The Conference Board Measure of CEO Confidence™ in collaboration with The Business Council improved further in the first quarter of 2021, following a sharp increase in the previous survey, conducted in September 2020. The measure now stands at 73, up from 64. This marks the highest level of CEO confidence since Q1 2004, when the measure stood at 74. (A reading above 50 points reflects more positive than negative responses.) 

The outlook for employees’ wages has improved, while the potential for layoffs has receded. In Q1, 36 percent of CEOs foresaw increasing their employees’ wages by more than 3 percent over the next 12 months, compared with 22 percent in the previous survey. Moreover, just 12 percent CEOs said they anticipated reducing their workforce over the next 12 months, down from 34 percent. Talent shortages appear to be slowly reemerging: In Q1, business leaders reporting some trouble attracting qualified workers, in key or several areas, increased from 36 percent to 49 percent. 

«With the vaccine rollout underway in major economies, CEOs entered 2021 historically upbeat,» said Dana Peterson, Chief Economist of The Conference Board. «They foresee the economy improving further over the next six months. However, setbacks from the pandemic remain a risk to future growth.»

Overall, 82 percent of CEOs expected economic conditions to improve over the next six months, up from 63 percent in the previous survey. The proportion expecting conditions to worsen was cut in half—from 15 percent to 7 percent. Similarly, 78 percent of CEOs anticipate short-term prospects in their own industries to improve, up from 65 percent last September.

«CEOs across industries are planning for life after COVID-19,» said Roger W. Ferguson, Jr., Vice Chairman of The Business Council and Trustee of The Conference Board. «If downside risks are avoided, then this optimism will likely translate into higher wages, employment, and capital spending over the next year.» 

Current Conditions
CEOs’ assessment of general economic conditions remained positive overall in Q1:

• 67 percent of CEOs reported economic conditions were better compared to six months ago, down slightly from 70 percent
• However, only 10 percent said conditions were worse, down from 21 percent

CEOs remained optimistic about conditions in their own industries in Q1 compared to the prior survey:

• 68 percent of CEOs reported conditions in their industries were better compared to six months ago, unchanged from the September survey
• However, only 8 percent said conditions were worse in their own industries, down from 20 percent  

Future Conditions
Expectations about the short-term economic outlook improved considerably in Q1 over the previous survey:

• 82 percent of CEOs expected economic conditions to improve over the next six months, up from 63 percent
• Moreover, only 7 percent expected conditions to worsen, down from 15 percent 

CEOs’ expectations regarding short-term prospects in their own industries also improved in Q1:

• 78 percent of CEOs anticipated improved conditions in their industry, up from 65 percent
• 7 percent expected conditions to worsen, down from 11 percent

Capital Spending, Employment, Recruiting, and Wages
The survey also gauged CEOs’ expectations about four key actions their companies plan on taking over the next 12 months.

• Capital Spending: 45 percent of CEOs expected to increase their capital budgets in the year ahead, while 15 percent anticipated decreasing spending, compared with 25 percent and 37 percent, respectively
• Employment: 47 percent of CEOs expected to expand their workforce; up from 33 percent in the September survey
• Hiring Qualified People: 50 percent of CEOs expected  few, if any, problems finding qualified workers, down from 62 percent
• Wages: 36 percent of CEOs expect to increase wages by 3 percent or more; just 1 percent foresee wage cuts

Source: CEO Confidence Survey, January 2021 / The Conference Board
The CEO Confidence survey was fielded from January 14^th through January 29^th.

About The Conference Board
The Conference Board is the member-driven think tank that delivers trusted insights for what’s ahead. Founded in 1916, we are a non-partisan, not-for-profit entity holding 501 (c) (3) tax-exempt status in the United States. www.conference-board.org

About The Business Council
The Business Council is a forum for the CEOs of the world’s largest multinational corporations across all industry sectors. Members gather several times each year to share best practices, network and engage in intellectually provocative, enlightening discussions with peers and thought-leaders in business, government, academia, science, technology and other disciplines. Through the medium of discussion, the Council seeks to foster greater understanding of the major opportunities and challenges facing business, and to create consensus for solutions. Visit The Business Council’s website at www.thebusinesscouncil.org 

View original content to download multimedia:http://www.prnewswire.com/news-releases/ceo-confidence-increased-to-a-17-year-high-in-q1-2021-301231039.html

SOURCE The Conference Board

CHICAGO, Feb. 18, 2021 /PRNewswire/ –The Urban Health Report (UHR), a digital health and wellness hub dedicated to eliminating health disparities in Black, indigenous and people of color (BIPOC) communities, launches with the UHR Holistic Health 100 list. The list of holistic health heroes was uniquely curated to recognize individuals who prompt innovative action, support and represent resilient holistic change in the lives of BIPOC.

«We decided to launch the UHR last spring upon hearing about the impact of the racial health disparities amongst BIPOC, exacerbated by the coronavirus pandemic,» states UHR Founder Robert Ingram. «Inspiring greater possibilities for BIPOC will be a strategic and collaborative effort of grass-roots level community, culture influencers, creators of clear pathways to healthcare careers and the continual engagement and accountability of congress and corporate entities. Anything less will render efforts for comprehensive and holistic change for BIPOC ineffective and anemic,» intones UHR Co-Founder, Kayla Ingram. 

With this broadened perspective on holistic health and wellness by way of community, culture, corporate, careers and congress, individuals honored on this list challenge the world to reimagine BIPOC existence, holistically––body, mind and soul. Heading the list of honorees are President Joseph Biden, Vice President Kamala Harris and select members of the White House Coronavirus Task Force. Also at the top is Johnson & Johnson Chairman, CEO, Alex Gorsky, Merck CEO, Kenneth Frazier and Walgreens CEO, Rosalind Brewer.

A sample of other notables on the list includes Michael Sneed, J&J,  Dr. Valerie Montgomery Rice, Morehouse School of Medicine, Dr. Makaya Douoguih, Janssen, Dr. Wayne A. I. Frederick, Howard University School of Medicine, Vanessa Broadhurst, J&J, Dr. James E. K. Hiildreth, Meharry Medical College, Dr. David M. Carlisle, Charles R. Drew University of Medicine and Science, Courtney Billington, Janssen Neuroscience, Thomas Harvey, AT&T, Keith Sanders, CDW, Lebron James, NBA Great, Joan Robinson Berry, The Boeing Company, Calvin Butler, Exelon and Staci Hargraves, Janssen R&D.

Visit urbanhealthreport.org for more information and UHR’s Holistic Health 100 list.

About UHR

The Urban Health Report (UHR) exists to eliminate health disparities in BIPOC communities by emboldening BIPOC and the entities that seek to serve them.

Contact:

Kayla Ingram
291840@email4pr.com
4104047895

View original content to download multimedia:http://www.prnewswire.com/news-releases/urban-health-report-announces-holistic-health-100-list-301231018.html

SOURCE The Urban Health Report